Bosentan 62.5 mg is an oral medication primarily used in the management of Pulmonary Arterial Hypertension (PAH). Bosentan belongs to a class of medicines known as endothelin receptor antagonists. It works by blocking the action of endothelin-1, a natural substance in the body that causes narrowing of blood vessels. By relaxing and widening the blood vessels in the lungs, Bosentan reduces pulmonary blood pressure and improves exercise capacity. This medicine is commonly prescribed for patients diagnosed with Pulmonary Arterial Hypertension, including cases associated with connective tissue diseases or congenital heart disease. Bosentan 62.5 mg is often used as an initial dose before increasing to maintenance strength, as directed by a healthcare professional.
